Sort   by:  
 Page size 
ProteomicsPeptide probes containing a non-hydrolyzable phosphotyrosine-mimetic residue as a tool for tyrosine phosphatomics
Protein tyrosine phosphatases (PTPs) cooperate with protein tyrosine kinases to regulate intracellular tyrosine phosphorylation levels, and their dysfunction is associated with various diseases. However, due to the low abundance of PTPs in cells, comprehensive analysis requires an enrichment step pr...
ORGANISM(S): Homo Sapiens (human) 
2021-10-27 | PXD025038 | JPOST Repository
ProteomicsRNA pulldown-MS, Dlg4 RNA in mouse brain
Goal was to identify RNA-binding proteins with a preference for m6A-modified RNA using an RNA bait generated from a known m6A site in the Dlg4 (PSD-95) mRNA 3`-UTR. By comparison of differential enrichment between m6A-RNA pulldown fractions and A-RNA or no RNA fractions, we can identify m6A-binding ...
ORGANISM(S): Mus musculus (Mouse) 
2022-10-13 | PXD034159 | Pride
Pulldown M6a Rna Lc-ms/ms 
ProteomicsRNA pulldown-MS, Dlg4 RNA in mHippoE-2 cells
Goal was to identify RNA-binding proteins with a preference for m6A-modified RNA using an RNA bait generated from a known m6A site in the Dlg4 (PSD-95) mRNA 3`-UTR. By comparison of differential enrichment between m6A-RNA pulldown fractions and A-RNA or no RNA fractions, we can identify m6A-binding ...
ORGANISM(S): Mus musculus (Mouse) 
2022-10-13 | PXD034161 | Pride
Pulldown M6a Rna Lc-ms/ms 
ProteomicsKinase Inhibitor Pulldown Assay (KiP) for Clinical Proteomics
Protein kinases are frequently dysregulated and/or mutated in cancer and represent essential targets for therapy. Accurate quantification is essential, but current approaches are inadequate. For breast cancer treatment for example, the identification and quantification of the protein kinase ERBB2 is...
ORGANISM(S): Homo sapiens (Human) 
2024-01-26 | PXD044655 | Pride
Human Breast Cancer Kinase 
ProteomicsKinase Inhibitor Pulldown Assay (KiP) for Clinical Proteomics (SureQuant)
Protein kinases are frequently dysregulated and/or mutated in cancer and represent essential targets for therapy. Accurate quantification is essential, but current approaches are inadequate. For breast cancer treatment for example, the identification and quantification of the protein kinase ERBB2 is...
ORGANISM(S): Homo sapiens (Human) 
2024-01-26 | PXD046169 | Pride
Breast cancer Is-prm Surequant Kip 
ProteomicsLinc-ADAIN Pulldown assay in Human Adipocytes.
Description: a biotinylated pulldown assay of linc-ADAIN, lincRNA vs Antisense Linc-ADAIN in primary human ASC adipocytes coupled to mass spectrometry (MS).
ORGANISM(S): Homo sapiens (Human) 
2024-10-17 | PXD051388 | Pride
Pulldown assay Linc-rna protein interaction Adipocytes Lincrna Linc-adain 
ProteomicsLFQ-MS analysis of nucleosome pulldown experiments with symmetric and asymmetric nucleosomes
Recombinant mononucleosomes were generated carrying H3K4me3 and H3K27me3 in symmetric or asymmetric monovalent or asymmetric bivalent conformation, immobilized on beads and subjected to pulldown assays with mouse ESC nuclear extract. Binding was analyzed by quantitative LFQ-MS.
ORGANISM(S): Mus musculus (Mouse) 
2025-01-02 | PXD015990 | Pride
Chromatin Transcription Histone acetylation Embryonic stem cells Differentiation Bivalent domains Histone methylation 
UnknownKinase inhibitor pulldown assay (KiP) for clinical proteomics.
Not available
S-EPMC10790396 | biostudies-literature
UnknownKey aromatic/hydrophobic amino acids controlling a cross-amyloid peptide interaction versus amyloid self-assembly.
Not available
S-EPMC5582850 | biostudies-literature
UnknownEstablishing selectivity of FAK-paxillin PPI inhibitor using pulldown proteomics and a focal adhesion protein selectivity panel.
Not available
S-EPMC12765108 | biostudies-literature
Sort   by:  
 Page size